Development of human serum albumin conjugated with near-infrared dye for photoacoustic tumor imaging

Journal of Biomedical Optics

Volumn 19, Issue 9, 2014, Pages

  Kanazaki, Kengo ^a   Sano, Kohei ^b,c   Makino, Akira ^b,d   Takahashi, Atsushi ^a   Deguchi, Jun ^b   Ohashi, Manami ^b   Temma, Takashi ^b   Ono, Masahiro ^b   Saji, Hideo ^b  

^a CANON INC   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY HOSPITAL   (Japan)

^d UNIVERSITY OF FUKUI   (Japan)

Author keywords

cancer; human serum albumin; indocyanine green; photoacoustic imaging

Indexed keywords

BODY FLUIDS; DISEASES; DYES; MAMMALS; NONINVASIVE MEDICAL PROCEDURES; PHOTOACOUSTIC EFFECT; TUMORS; ULTRASONIC APPLICATIONS;

CANCER; ENHANCED PERMEABILITY AND RETENTION EFFECT; HUMAN SERUM ALBUMINS; INDOCYANINE GREEN; NEAR-INFRARED DYES; NON-INVASIVE DIAGNOSTICS; PHOTO-ACOUSTIC IMAGING; SIGNAL INTENSITIES;

DIAGNOSIS;

INDIUM; INDOCYANINE GREEN; PENTETIC ACID; SERUM ALBUMIN;

ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; FEMALE; FLUORESCENCE IMAGING; HUMAN; MOUSE; NEOPLASMS; PATHOLOGY; PHOTOACOUSTICS; PROCEDURES; TISSUE DISTRIBUTION; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; FEMALE; HUMANS; INDIUM RADIOISOTOPES; INDOCYANINE GREEN; MICE; MICE, INBRED BALB C; NEOPLASMS; OPTICAL IMAGING; PENTETIC ACID; PHOTOACOUSTIC TECHNIQUES; SERUM ALBUMIN; TISSUE DISTRIBUTION;

EID: 84911486504     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.JBO.19.9.096002     Document Type: Article

References (34)

1. D. Razansky et al., "Deep tissue optical and optoacoustic molecular imaging technologies for pre-clinical research and drug discovery," Curr. Pharm. Biotechnol. 13(4), 504-522 (2012).
2. V. Ntziachristos, "Going deeper than microscopy: the optical imaging frontier in biology," Nat. Methods. 7(8), 603-614 (2010).
3. J. Laufer et al., "In vivo preclinical photoacoustic imaging of tumor vasculature development and therapy," J. Biomed. Opt. 17(5), 056016 (2012).
4. G. P. Luke, D. Yeager, and S. Y. Emelianov, "Biomedical applications of photoacoustic imaging with exogenous contrast agents," Ann. Biomed. Eng. 40(2), 422-437 (2012).
5. G. Ku and L. V. Wang, "Deeply penetrating photoacoustic tomography in biological tissues enhanced with an optical contrast agent," Opt. Lett. 30(5), 507-509 (2005).
6. W. J. Akers et al., "Multimodal sentinel lymph node mapping with single-photon emission computed tomography (SPECT)/computed tomography (CT) and photoacoustic tomography," Transl. Res. 159(3), 175-181 (2012).
7. D. Pan et al., "Near infrared photoacoustic detection of sentinel lymph nodes with gold nanobeacons," Biomaterials 31(14), 4088-4093 (2010).
8. A. de la Zerda et al., "Family of enhanced photoacoustic imaging agents for high-sensitivity and multiplexing studies in living mice," ACS Nano 6(6), 4694-4701 (2012).
9. G. Kim et al., "Indocyanine-green-embedded PEBBLEs as a contrast agent for photoacoustic imaging," J. Biomed. Opt. 12(4), 044020 (2007).
10. J. V. Frangioni, "In vivo near-infrared fluorescence imaging," Curr. Opin. Chem. Biol. 7(5), 626-634 (2003).
11. V. L. Dzurinko, A. S. Gurwood, and J. R. Price, "Intravenous and indocyanine green angiography," Optometry 75(12), 743-755 (2004).
12. S. G. Sakka, "Assessing liver function," Curr. Opin. Crit. Care 13(2), 207-214 (2007).
13. Y. Ishima et al., "S-Nitrosated human serum albumin dimer is not only a novel anti-tumor drug but also a potentiator for anti-tumor drugs with augmented EPR effects," Bioconjug. Chem. 23(2), 264-271 (2012).
14. B. Elsadek and F. Kratz "Impact of albumin on drug delivery - new applications on the horizon," J. Control. Release 157(1), 4-28 (2012).
15. H. Maeda, "Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects," Bioconjug. Chem. 21(5), 797-802 (2010).
16. H. Maeda and Y. Matsumura, "EPR effect based drug design and clinical outlook for enhanced cancer chemotherapy," Adv. Drug Deliv. Rev. 63(3), 129-130 (2011).
17. J. R. Cook, R. R. Bouchard, and S. Y. Emelianov, "Tissue-mimicking phantoms for photoacoustic and ultrasonic imaging," Biomed. Opt. Express 2(11), 3193-3206 (2011).
18. A. Krumholz et al., "Multicontrast photoacoustic in vivo imaging using near-infrared fluorescent proteins," Sci. Rep. 4, 3939 (2014).
19. Y. Wang and L. V. Wang, "Förster resonance energy transfer photoacoustic microscopy," J. Biomed. Opt. 17(8), 086007 (2012).
20. T. W. Evans, "Review article: albumin as a drug - biological effects of albumin unrelated to oncotic pressure," Aliment. Pharmacol. Ther. 16(Suppl 5), 6-11 (2002).
21. G. R. Cherrick et al., "Indocyanine green: observations on its physical properties, plasma decay, and hepatic extraction," J. Clin. Invest. 39(4), 592-600 (1960).
22. C. A. Dawson et al., "Influence of plasma protein on the inhibitory effects of indocyanine green and bromcresol green on pulmonary prostaglandin E1 extraction," Br. J. Pharmacol. 81(3), 449-455 (1984).
23. M. Mehrmohammadi et al., "Photoacoustic imaging for cancer detection and staging," Curr. Mol. Imag. 2(1), 89-105 (2013).
24. Z. Liu et al.," In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice," Nat. Nanotechnol. 2(1), 47-52 (2007).
25. C. Kim et al.," In vivo molecular photoacoustic tomography of melanomas targeted by bioconjugated gold nanocages," ACS Nano 4(8), 4559-4564 (2010).
26. A. de la Zerda et al., "Advanced contrast nanoagents for photoacoustic molecular imaging, cytometry, blood test and photothermal theranostics," Contrast Media Mol. Imaging 6(5), 346-369 (2011).
27. S. T. Yang et al., "Long-term accumulation and low toxicity of singlewalled carbon nanotubes in intravenously exposed mice," Toxicol. Lett. 181(3), 182-189 (2008).
28. L. Nie et al., "In vivo volumetric photoacoustic molecular angiography and therapeutic monitoring with targeted plasmonic nanostars," Small 10(8), 1585-1593 (2014).
29. J. L. Tullis, "Albumin. 2 Guidelines for clinical use," J. Am. Med. Assoc. 237(5), 460-463 (1977).
30. L. C. Vermeulen, Jr. et al., "A paradigm for consensus. The University Hospital Consortium guidelines for the use of albumin, nonprotein colloid, and crystalloid solutions," Arch. Int. Med. 155(4), 373-379 (1995).
31. C. M. Mendez, C. J. McClain, and L. S. Marsano, "Albumin therapy in clinical practice," Nutr. Clin. Pract. 20(3), 314-320 (2005).
32. K. Sano et al.," In vivo breast cancer characterization imaging using two monoclonal antibodies activatably labeled with near infrared fluorophores," Breast Cancer Res. 14(2), R61 (2012).
33. K. Sano et al., "Short PEG-linkers improve the performance of targeted, activatable monoclonal antibody-indocyanine green optical imaging probes," Bioconjugate Chem. 24(5), 811-816 (2013).
34. K. Sano et al., "Activatable fluorescent cys-diabody conjugated with indocyanine green derivative: consideration of fluorescent catabolite kinetics on molecular imaging," J. Biomed. Opt. 18(10), 101304 (2013).